vTv Therapeutics Inc. (VTVT)
vTv Therapeutics Statistics
Share Statistics
vTv Therapeutics has 2.61M shares outstanding. The number of shares has increased by 7.37% in one year.
| Shares Outstanding | 2.61M |
| Shares Change (YoY) | 7.37% |
| Shares Change (QoQ) | 7.37% |
| Owned by Institutions (%) | 4.23% |
| Shares Floating | 1.48M |
| Failed to Deliver (FTD) Shares | 14 |
| FTD / Avg. Volume | 0.09% |
Short Selling Information
The latest short interest is 28.85K, so 1.1% of the outstanding shares have been sold short.
| Short Interest | 28.85K |
| Short % of Shares Out | 1.1% |
| Short % of Float | 1.94% |
| Short Ratio (days to cover) | 1.5 |
Valuation Ratios
The PE ratio is -1.18 and the forward PE ratio is -2.98. vTv Therapeutics's PEG ratio is 0.05.
| PE Ratio | -1.18 |
| Forward PE | -2.98 |
| PS Ratio | 0 |
| Forward PS | null |
| PB Ratio | -0.97 |
| P/FCF Ratio | -1.26 |
| PEG Ratio | 0.05 |
Enterprise Valuation
Currently the Enterprise Value (EV) is not available for vTv Therapeutics Inc..
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1, with a Debt / Equity ratio of -0.02.
| Current Ratio | 1 |
| Quick Ratio | 1 |
| Debt / Equity | -0.02 |
| Total Debt / Capitalization | -2.19 |
| Cash Flow / Debt | -36.07 |
| Interest Coverage | -1961.69 |
Financial Efficiency
Return on equity (ROE) is 0.82% and return on capital (ROIC) is 141.52%.
| Return on Equity (ROE) | 0.82% |
| Return on Assets (ROA) | -1.84% |
| Return on Capital (ROIC) | 141.52% |
| Revenue Per Employee | 0 |
| Profits Per Employee | -1.27M |
| Employee Count | 16 |
| Asset Turnover | 0 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | 0 |
| Effective Tax Rate | 0 |
Stock Price Statistics
The stock price has increased by 18.79% in the last 52 weeks. The beta is 0.72, so vTv Therapeutics's price volatility has been higher than the market average.
| Beta | 0.72 |
| 52-Week Price Change | 18.79% |
| 50-Day Moving Average | 16.02 |
| 200-Day Moving Average | 16.96 |
| Relative Strength Index (RSI) | 58.44 |
| Average Volume (20 Days) | 15.06K |
Income Statement
| Revenue | n/a |
| Gross Profit | -13.6M |
| Operating Income | -25.5M |
| Net Income | -20.25M |
| EBITDA | -25.41M |
| EBIT | n/a |
| Earnings Per Share (EPS) | -9.71 |
Balance Sheet
The company has 9.45M in cash and 529K in debt, giving a net cash position of 8.92M.
| Cash & Cash Equivalents | 9.45M |
| Total Debt | 529K |
| Net Cash | 8.92M |
| Retained Earnings | -281.04M |
| Total Assets | 43.16M |
| Working Capital | 36.53M |
Cash Flow
In the last 12 months, operating cash flow was -19.08M and capital expenditures 0, giving a free cash flow of -19.08M.
| Operating Cash Flow | -19.08M |
| Capital Expenditures | 0 |
| Free Cash Flow | -19.08M |
| FCF Per Share | -9.15 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
VTVT does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Payout Ratio | n/a |
| Earnings Yield | -49.39% |
| FCF Yield | -37.15% |
Analyst Forecast
The average price target for VTVT is $35, which is 78% higher than the current price. The consensus rating is "Buy".
| Price Target | $35 |
| Price Target Difference | 78% |
| Analyst Consensus | Buy |
| Analyst Count | 1 |
Stock Splits
The last stock split was on Nov 21, 2023. It was a backward split with a ratio of 1:40.
| Last Split Date | Nov 21, 2023 |
| Split Type | backward |
| Split Ratio | 1:40 |
Scores
| Altman Z-Score | -9.11 |
| Piotroski F-Score | 2 |